Shigeyuki Kataoka is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on developing novel compounds that have therapeutic applications.

Latest Patents

Kataoka's latest patents include a nicotinamide derivative and a novel compound, 1,2-bis(nicotinamido)propane, along with its pharmaceutically acceptable salts. These inventions are designed to prevent or spasmolyse cerebral vasospasms, prevent cerebral apoplexy, and lower lipoperoxide levels in the blood. Another notable patent is for a tetrahydronicotinamide derivative, which has been shown to suppress platelet aggregation and exhibit anti-inflammatory, antipyretic, and analgesic actions.

Career Highlights

Kataoka is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Some of his notable coworkers include Sakae Takaku and Minoru Shindo, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Shigeyuki Kataoka's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com